Clinical Trial Update: Decitabine in Combination With Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating decitabine in combination with low-dose cytarabine for elderly patients with acute myeloid leukemia; current status is UNKNOWN…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Cytarabine (Low-Dose) (cytarabine)
• Dacogen (decitabine)

Snippet

Sponsor: Chunyan Ji | Conditions: Acute Myeloid Leukemia, Adult | Phase 3 | Status: UNKNOWN